This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 14 - 17, 2025
Marriott Marquis San DiegoLive In-Person Event: December 14 - 17, 2025

Gerlinde Wernig, PhD
Associate Professor at Stanford Medicine
Speaker

Profile

Dr. Gerlinde Wernig is an Associate Professor at Stanford University and a quadruple board-certified physician-scientist with training in pathology and internal medicine/hematology/oncology. As a principal investigator at Stanford’s Institute for Regenerative Medicine and Stem Cell Research and the department of Pathology, she leads a lab studying immunology and fibrotic diseases, focusing on the role of the transcription factor JUN as a master regulator in fibrosis. Her research aims to uncover the mechanisms driving fibrosis and its intersection with immunity, with the goal of developing targeted therapies for life-threatening fibrotic diseases such as IPF, which currently lack effective treatments. https://www.gerlindewerniglaboratory.org/

Agenda Sessions

  • Towards Bispecific Biologics to Treat Interstitial Lung Disease

    4:15pm